Ragosa Mark
CHIEF FINANCIAL OFFICER · 31 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 1,303 | $48.94 | $63,768.82 | filing |
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,694 | — | — | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 2,510 | $48.13 | $120,806.30 | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 5,187 | — | — | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 18,741 | $46.24 | $866,583.84 | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 17,981 | $45.58 | $819,573.98 | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 10,360 | $26.74 | $277,026.40 | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 13,813 | $18.06 | $249,462.78 | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 10,513 | $17.76 | $186,710.88 | filing |
| 2026-03-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,036 | $22.89 | $46,604.04 | filing |
| 2026-02-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 9,114 | $42.85 | $390,534.90 | filing |
| 2026-02-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 8,731 | $43.72 | $381,719.32 | filing |
| 2026-02-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 8,374 | $12.97 | $108,610.78 | filing |
| 2026-02-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,471 | $16.90 | $41,759.90 | filing |
| 2026-01-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 12,000 | $41.89 | $502,680.00 | filing |
| 2025-12-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 42,841 | $41.49 | $1.8M | filing |
| 2025-12-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 16,165 | $11.97 | $193,495.05 | filing |
| 2025-12-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 16,164 | $11.10 | $179,420.40 | filing |
| 2025-12-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 10,512 | $10.76 | $113,109.12 | filing |
| 2025-11-12 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 19,900 | $40.94 | $814,706.00 | filing |
| 2025-11-12 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 19,900 | $30.93 | $615,507.00 | filing |
| 2025-10-28 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 100 | $41.00 | $4,100.00 | filing |
| 2025-10-28 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 100 | $30.93 | $3,093.00 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 900 | $34.28 | $30,852.00 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 1,861 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 2,920 | $33.49 | $97,790.80 | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 1,750 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,694 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 1,592 | — | — | filing |
| 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 18,889 | $32.89 | $621,259.21 | filing |
| 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 18,889 | $22.89 | $432,369.21 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.